Xue-Jun Song Selected Research

Indicators and Reagents (Reagents)

7/2011	Blocking EphB1 receptor forward signaling in spinal cord relieves bone cancer pain and rescues analgesic effect of morphine treatment in rodents.
1/2011	Topical application of compound Ibuprofen suppresses pain by inhibiting sensory neuron hyperexcitability and neuroinflammation in a rat model of intervertebral foramen inflammation.
11/2008	Targeted mutation of EphB1 receptor prevents development of neuropathic hyperalgesia and physical dependence on morphine in mice.
9/2008	EphrinB-EphB receptor signaling contributes to neuropathic pain by regulating neural excitability and spinal synaptic plasticity in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xue-Jun Song Research Topics

Disease

27	Hyperalgesia 01/2023 - 04/2003
25	Pain (Aches) 04/2024 - 03/2005
15	Neuralgia (Stump Neuralgia) 06/2022 - 03/2005
9	Bone Neoplasms (Bone Cancer) 01/2023 - 07/2011
8	Inflammation (Inflammations) 01/2020 - 03/2005
7	Peripheral Nerve Injuries 01/2020 - 05/2005
4	Chronic Pain 04/2024 - 02/2009
4	Diabetic Neuropathies (Diabetic Neuropathy) 10/2023 - 10/2021
3	Hypersensitivity (Allergy) 06/2022 - 09/2008
3	Cancer Pain 01/2021 - 01/2015
3	Neoplasms (Cancer) 08/2019 - 08/2014
3	Ganglion Cysts (Ganglion) 10/2012 - 09/2003
3	Opioid-Related Disorders (Opiate Addiction) 06/2010 - 11/2008
2	Neuroinflammatory Diseases 04/2023 - 01/2011
2	COVID-19 01/2021 - 11/2020
2	Morphine Dependence 06/2010 - 11/2008
1	Intractable Pain 04/2024
1	Tendon Injuries 04/2024
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2023
1	Carpal Tunnel Syndrome 10/2023
1	Complex Regional Pain Syndromes 10/2023
1	Postherpetic Neuralgia 10/2023
1	Avitaminosis (Vitamin Deficiency) 10/2023
1	Dermatitis 10/2023
1	Demyelinating Diseases (Demyelinating Disease) 10/2021
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2020
1	Spinal Cord Ischemia 10/2017
1	Postoperative Pain 01/2016

Drug/Important Bio-Agent (IBA)

9	Analgesics (Analgesic Drugs)IBA 04/2024 - 03/2005
7	CytokinesIBA 04/2023 - 12/2013
6	Vitamin B Complex (B Vitamins)IBA 04/2024 - 03/2005
6	Eph Family Receptors (Eph Receptors)IBA 01/2020 - 09/2008
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 04/2003
6	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 11/2008
5	Proteins (Proteins, Gene)FDA Link 08/2019 - 10/2008
4	CateninsIBA 04/2023 - 05/2013
4	Phosphotransferases (Kinase)IBA 01/2020 - 09/2008
4	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 08/2014 - 01/2006
4	EphB1 ReceptorIBA 12/2013 - 11/2008
4	Indicators and Reagents (Reagents)IBA 07/2011 - 09/2008
3	Thiamine (Aneurin)FDA Link 04/2024 - 03/2005
3	Peptides (Polypeptides)IBA 04/2024 - 07/2012
3	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 09/2008
3	Adenosine Monophosphate (AMP)IBA 08/2014 - 11/2011
3	SodiumIBA 04/2014 - 05/2008
2	Pyridoxine (Pyridoxin)FDA LinkGeneric 04/2024 - 03/2005
2	PAR-2 ReceptorIBA 04/2024 - 07/2012
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 04/2024 - 03/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2023 - 01/2016
2	Opioid Receptors (Opioid Receptor)IBA 01/2023 - 01/2020
2	Streptozocin (Streptozotocin)FDA Link 06/2022 - 10/2021
2	Blood Glucose (Blood Sugar)IBA 06/2022 - 04/2014
2	GelatinasesIBA 10/2021 - 06/2010
2	Ion Channels (Ion Channel)IBA 01/2021 - 08/2019
2	Opioid Analgesics (Opioids)IBA 01/2020 - 06/2010
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2016 - 01/2006
2	Hematoxylin (Haematoxylon)IBA 01/2016 - 01/2006
2	salicylhydroxamic acid (SHAM)IBA 08/2014 - 09/2003
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 04/2014 - 11/2011
2	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 01/2007 - 01/2006
1	VitaminsIBA 10/2023
1	LipopolysaccharidesIBA 04/2023
1	Interleukin-6 (Interleukin 6)IBA 04/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2023
1	SolutionsIBA 01/2023
1	Butyrates (Butyrate)IBA 01/2023
1	Butyric Acid (Butanoic Acid)IBA 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2022
1	Colchicine FDA LinkGeneric 05/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	verubecestatIBA 01/2022
1	Thioctic Acid (Lipoic Acid)IBA 10/2021
1	Matrix Metalloproteinases (MMPs)IBA 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	InterferonsIBA 07/2020
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2020
1	Freund's AdjuvantIBA 01/2020
1	Naloxone (Narcan)FDA LinkGeneric 01/2020
1	src-Family KinasesIBA 01/2020
1	erythromycin propionate-N-acetylcysteinateIBA 08/2019
1	Cyclic NucleotidesIBA 08/2019
1	Opiate AlkaloidsIBA 10/2017
1	ImmunosorbentsIBA 01/2016
1	InterleukinsIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	EnzymesIBA 01/2016
1	lysophosphatidic acidIBA 01/2016

Therapy/Procedure

3	Therapeutics 10/2021 - 03/2005
2	Analgesia 04/2024 - 02/2009
2	Drug Therapy (Chemotherapy) 10/2023 - 06/2022
2	Rhizotomy 05/2022 - 11/2008
2	Pain Management 01/2021 - 11/2020
2	Radiotherapy 08/2019 - 01/2016
2	Spinal Manipulation 01/2016 - 01/2006
2	Musculoskeletal Manipulations (Manipulative Therapy) 01/2016 - 01/2006
2	Intraperitoneal Injections 04/2014 - 03/2005
1	Transplantation 06/2022
1	Immunomodulation 07/2020
1	Decompression 01/2016